Albar Capital Partners LLP Acquires New Stake in GE HealthCare Technologies Inc. $GEHC

Key Points

• Albar Capital Partners LLP has acquired a new position in GE HealthCare Technologies Inc. with 164,486 shares valued at approximately $13.3 million, making it their 7th largest holding.
• GE HealthCare Technologies reported earnings of $1.06 per share for the latest quarter, exceeding estimates, while revenue was $5 billion, marking a year-over-year increase of 3.5%.
• Institutional investors own 82.06% of GE HealthCare Technologies, indicating significant confidence from institutions in the company's growth potential.

Albar Capital Partners LLP bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 164,486 shares of the company's stock, valued at approximately $13,276,000. GE HealthCare Technologies comprises 6.0% of Albar Capital Partners LLP's investment portfolio, making the stock its 7th biggest position.

Several other hedge funds have also bought and sold shares of GEHC. N.E.W. Advisory Services LLC purchased a new position in shares of GE HealthCare Technologies during the 1st quarter valued at about $25,000. Bogart Wealth LLC raised its holdings in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after buying an additional 247 shares in the last quarter. Stonebridge Financial Group LLC raised its holdings in shares of GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after buying an additional 222 shares in the last quarter. Accredited Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $30,000. Finally, LGT Financial Advisors LLC grew its position in GE HealthCare Technologies by 46.2% during the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after acquiring an additional 123 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Up 0.9%

Shares of NASDAQ GEHC traded up $0.62 during mid-day trading on Wednesday, hitting $72.22. 1,263,723 shares of the stock traded hands, compared to its average volume of 3,954,371. The stock has a fifty day moving average price of $74.27 and a 200-day moving average price of $74.40. The company has a market cap of $32.97 billion, a price-to-earnings ratio of 14.81, a PEG ratio of 2.82 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm's quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were paid a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is currently 2.87%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Morgan Stanley reduced their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Citigroup raised their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Wall Street Zen upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. Finally, Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $88.55.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.